The Business of RNAi Therapeutics in 2012
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2012-01-01
|
| Series: | Molecular Therapy: Nucleic Acids |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253116300683 |
| _version_ | 1818652913401069568 |
|---|---|
| author | Dirk Haussecker |
| author_facet | Dirk Haussecker |
| author_sort | Dirk Haussecker |
| collection | DOAJ |
| first_indexed | 2024-12-17T02:29:33Z |
| format | Article |
| id | doaj.art-80d1e648181445d9be5e81a910a6797f |
| institution | Directory Open Access Journal |
| issn | 2162-2531 |
| language | English |
| last_indexed | 2024-12-17T02:29:33Z |
| publishDate | 2012-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Molecular Therapy: Nucleic Acids |
| spelling | doaj.art-80d1e648181445d9be5e81a910a6797f2022-12-21T22:07:00ZengElsevierMolecular Therapy: Nucleic Acids2162-25312012-01-011C10.1038/mtna.2011.9The Business of RNAi Therapeutics in 2012Dirk Haussecker0Department of Medical Biotechnology, College of Natural Sciences, Dongguk University, Seoul, Koreahttp://www.sciencedirect.com/science/article/pii/S2162253116300683 |
| spellingShingle | Dirk Haussecker The Business of RNAi Therapeutics in 2012 Molecular Therapy: Nucleic Acids |
| title | The Business of RNAi Therapeutics in 2012 |
| title_full | The Business of RNAi Therapeutics in 2012 |
| title_fullStr | The Business of RNAi Therapeutics in 2012 |
| title_full_unstemmed | The Business of RNAi Therapeutics in 2012 |
| title_short | The Business of RNAi Therapeutics in 2012 |
| title_sort | business of rnai therapeutics in 2012 |
| url | http://www.sciencedirect.com/science/article/pii/S2162253116300683 |
| work_keys_str_mv | AT dirkhaussecker thebusinessofrnaitherapeuticsin2012 AT dirkhaussecker businessofrnaitherapeuticsin2012 |